Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome – A systematic review and meta-analysis of randomized controlled trials
Open accessAbstract
This updated systematic review aimed at evaluating the efficacy, acceptability and safety of cognitive behavioural therapies (CBTs) in fibromyalgia syndrome (FMS). Clinicaltrials.gov, Cochrane Library, MEDLINE, PsycINFO and SCOPUS were searched from September 2013 to May 2017. Randomized controlled trials (RCTs) comparing CBTs with controls were analysed. Primary outcomes were ≥50% pain relief, ≥20% improvement of health-related quality of life (HRQoL), negative mood, fatigue, disability, acceptability and safety at end of therapy and at 6 months follow-up. Effects were summarized by a random effects model using risk differences (RD) or standardized mean differences (SMD) with 95% confidence intervals (CI). 29 RCTs with 2509 subjects were included. CBTs were superior to controls (waiting list, attention control, treatment as usual, other active non-pharmacological therapies) in pain relief of 50% or greater (RD 0.05 [95% CI 0.02–0.07] (high-quality evidence), improvement of HRQoL of 20% or greater (RD 0.13 [95% CI 0.00–0.26], (moderate quality evidence), and in reducing negative mood (SMD −0.43 [95% CI −0.62 to −0.24]) (high-quality evidence), disability (SMD −0.30 [95% CI −0.52 to −0.08]) (high-quality evidence) and fatigue (SMD – 0–27 [95% CI −0.50 to −0.03]) (high-quality evidence). There were no statistically significant differences between CBTs and controls in acceptability and safety (high-quality evidence). The update did not change the major findings of the previous review. CBTs provided a clinically relevant benefit over control interventions in reducing some key symptoms of FMS and disability at the end of treatment. Significance: This updated systematic review with meta-analysis on cognitive behavioural therapies (CBTs) including acceptance-based CBTs endorse the efficacy and tolerability of CBTs in reducing key symptoms and disability in FMS in the short- and long-term if compared to waiting list, treatment as usual, attention controls and active non-pharmacological therapies. CBTs did not differ in efficacy except superiority for coping with pain and tolerability from recommended drug therapy (pregabalin and/or duloxetine).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
17 of 69 cited sources checked · 14 supported · 1 flagged · accuracy not yet measured
- Premisecitation
Across different reviews, cognitive behavioural therapy effect sizes on key fibromyalgia symptoms and disability ranged from small to moderate.
“The magnitude of the effects sizes of CBTs on the key symptoms of FMS and on disability ranged between small and moderate in different reviews (Thieme and Gracely, 2009;Glombiewski et al., 2010;Bernardy et al., 2013).”
Quote in the paperSubstantial claim1 of 3 sources checked - Premisecitation
Past cognitive behavioural therapy trials in fibromyalgia syndrome mostly reported average scores.
“However, CBT trials in FMS mostly reported average scores in the past (Bernardy et al., 2013).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Bernardy et al., 2013 source
- Premisecitation
Recent systematic reviews did not include acceptance-based studies.
“Recent systematic reviews did not include acceptance-based studies (Thieme and Gracely, 2009;Glombiewski et al., 2010;Bernardy et al., 2013).”
Quote in the paperSubstantial claim1 of 3 sources checked - Findingcitation
Two studies compared cognitive behavioural therapy with recommended pharmacological therapy (pregabalin and duloxetine).
“we added a comparison of two studies which compared to recommended pharmacological therapy (pregabalin andin case of depressive disorderduloxetine (Alda et al., 2011;Luciano et al., 2014).”
Quote in the paperNot a substantial claim1 of 2 sources checked - Study design and conductown data
Five included studies were classified as high quality with low overall risk of bias.
“According to the predefined categories five studies were high-quality studies (low risk of bias overall) (Alda et al., 2011;Luciano et al., 2011Luciano et al., , 2014;;Kashikar-Zuck et al., 2012;Karlsson et al., 2015)”
Quote in the paperNot a substantial claim1 of 3 sources checked
- Premisecitation
In earlier reviews of psychological therapies, it was impossible to obtain requested details from studies conducted before 2005.
“We have experienced in previous reviews on psychological therapies that it was impossible to get any details, on request, of studies conducted before 2005 (Bernardy et al., 2013).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Bernardy et al., 2013 source
- Interpretationnone given
The conclusions of the previous review by Bernardy et al. (2013) regarding the efficacy of traditional and operant cognitive behavioural therapies for reducing some key fibromyalgia symptoms and disability remain unchanged.
“The conclusions of our previous review (Bernardy et al., 2013) of the efficacy of (traditional, operant) CBTs to reduce some key symptoms and disability in FMS remain unchanged”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Bernardy et al., 2013 source
- Findingown data
The NNTB for pain relief of 50% or greater at long-term follow-up was 14 (95% CI 10-25).
“NNTB was 14 (95% CI 10-25).”
Quote in the paperSubstantial claim - Findingreasoning
In total, 29 studies with 31 study arms were included in qualitative and quantitative analysis.
“In sum, 29 studies with 31 study arms were included into the qualitative and quantitative analysis (see Fig. 1).”
Quote in the paperSubstantial claim - Findingown data
The risk difference for pain relief of 50% or greater at long-term follow-up was 0.07 (95% CI 0.04-0.10).
“RD was 0.07 (95% CI 0.04-0.10).”
Quote in the paperSubstantial claim - Findingown data
Median percentage of Caucasians was 93% (range 79-100%).
“The median percentage of Caucasians was 93% (79-100%).”
Quote in the paperNot a substantial claim - Findingown data
There was no statistically significant difference between CBTs and controls for safety at end of treatment (p=0.27).
“There was no statistically significant difference between CBTs and controls (p-value 0.27).”
Quote in the paperSubstantial claim - Findingown data
The risk difference for safety at end of treatment was 0.01 (95% CI -0.01 to 0.04).
“RD was 0.01 (95% CI À0.01 to 0.04).”
Quote in the paperNot a substantial claim - Findingown data
The standardized mean difference for reduction in disability at end of treatment was -0.30 (95% CI -0.52 to -0.08).
“SMD was À0.30 (95% CI À0.52 to À0.08).”
Quote in the paperSubstantial claim - Findingown data
The standardized mean difference for reduction in disability at long-term follow-up was -0.53 (95% CI -0.80 to -0.26).
“SMD was À0.53 (95% CI À0.80 to À0.26).”
Quote in the paperSubstantial claim - Findingown data
The standardized mean difference for reduction in negative mood at end of treatment was -0.43 (95% CI -0.62 to -0.24).
“SMD was À0.43 (95% CI À0.62 to À0.24).”
Quote in the paperSubstantial claim - Findingown data
The NNTB for pain relief of 50% or greater at end of treatment was 20 (95% CI 16-50).
“NNTB was 20 (95% CI 16-50).”
Quote in the paperSubstantial claim - Findingown data
The risk difference for pain relief of 50% or greater at end of treatment was 0.05 (95% CI 0.02-0.07).
“RD was 0.05 (95% CI 0.02-0.07).”
Quote in the paperSubstantial claim - Findingown data
The risk difference for improvement of health-related quality of life of 20% or greater at long-term follow-up was 0.19 (95% CI -0.03 to 0.40).
“RD was 0.19 (95% CI À0.03 to 0.40).”
Quote in the paperSubstantial claim - Findingown data
The risk difference for improvement of health-related quality of life of 20% or greater at end of treatment was 0.13 (95% CI 0.00-0.26).
“RD was 0.13 (95% CI 0.00-0.26).”
Quote in the paperSubstantial claim - Findingown data
There was no statistically significant difference between CBTs and controls for acceptability at end of treatment (p=0.45).
“There was no statistically significant difference between CBTs and controls (p-value 0.45).”
Quote in the paperSubstantial claim - Findingown data
The risk difference for acceptability at end of treatment was 0.01 (95% CI -0.02 to 0.05).
“RD was 0.01 (95% CI À0.02 to 0.05).”
Quote in the paperNot a substantial claim - Findingown data
The standardized mean difference for reduction in fatigue at end of treatment was -0.27 (95% CI -0.50 to -0.03).
“SMD was À0.27 (95% CI À0.50 to À0.03).”
Quote in the paperSubstantial claim - Findingown data
Five studies compared cognitive behavioural therapy with waiting list controls.
“five studies compared with waiting list controls”
Quote in the paperNot a substantial claim - Findingown data
The NNTB for improvement of health-related quality of life of 20% or greater at end of treatment was 8 (95% CI 4-100).
“NNTB was 8 (95% CI 4-100).”
Quote in the paperSubstantial claim - Findingown data
There were no statistically significant overall subgroup differences by type of CBTs at end of treatment for most outcomes.
“There were no statistically significant overall subgroup differences in the outcomes 50% and more pain relief (p-value 0.52), negative mood (p-value 0.10), disability (p-value 0.59), acceptability (p-value 0.13), 30% and more pain relief (p-value 0.16), mean pain intensity reduction (p-value 0.07) and coping with pain (p-value 0.14).”
Quote in the paperSubstantial claim - Findingown data
Removing studies with data substituted or extracted from figures did not change the magnitude and significance of the effect sizes of CBTs on pain, negative mood, and disability at end of treatment.
“Removing studies with data substituted or extracted from figures did not change the magnitude and significance of the effect sizes of CBTs on pain, negative mood and disability at end of treatment.”
Quote in the paperNot a substantial claim - Findingown data
There was considerable heterogeneity (I2 > 75%) in several comparisons at end of treatment and long-term follow-up.
“There was considerable heterogeneity (I² > 75%) in the comparisons improvement of HRQOL of 20% or greater, mean pain intensity and coping with pain at the end of treatment, and in the comparisons improvement of HRQOL of 20% or greater, negative mood, disability, coping with pain and sleep problems at long-term follow-up.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Methodological differences across studies explain the considerable heterogeneity observed.
- Findingown data
The test for overall subgroup differences was statistically significant for at least 20% improvement of HRQOL at end of treatment (p=0.03).
“The test for overall subgroup differences was statistically significant for at least 20% improvement of HRQOL (p-value 0.03).”
Quote in the paperNot a substantial claim - Findingown data
Subgroup analysis showed that cognitive behavioural therapies were efficacious in both children/adolescents and adults.
“(3) Subgroup analysis demonstrated the efficacy of CBTs in children and adolescents and in adults.”
Quote in the paperSubstantial claim - Findingown data
The included studies were conducted in university centres as well as in primary and secondary care.
“(1) The studies were not only performed in university centres but also in primary and secondary care.”
Quote in the paperSubstantial claim - Findingnone given
The majority of participants in the included studies were middle-aged Caucasian women.
“However, the majority of the participants were middle-aged Caucasian women”
Quote in the paperSubstantial claim - Findingown data
CBTs were not superior to controls in improvement of health-related quality of life of 20% or greater at long-term follow-up.
“CBTs were not superior to controls in improvement of health-related quality of life of 20% or greater at long-term follow-up.”
Quote in the paperSubstantial claim - Findingnone given
No evidence was found for benefit of self-management programmes used as single therapy.
“Evidence was not found for benefit of self management programmes as single therapy.”
Quote in the paperSubstantial claim - Findingown data
No included study conducted a subgroup analysis for male or non-Caucasian patients.
“No study performed a subgroup analysis for male and non-Caucasian patients.”
Quote in the paperSubstantial claim - Findingnone given
Traditional cognitive behavioural therapy, acceptance-based cognitive therapies, and operant therapy lasting 5 to 25 hours reduce some key fibromyalgia symptoms after 6 months.
“Traditional cognitive behavioural therapy, acceptance-based cognitive therapies and operant therapy between 5 and 25 h reduce some key symptoms of fibromyalgia after 6 months.”
Quote in the paperSubstantial claim - Findingown data
Excluding the studies with imputed or figure-extracted data from the analyses did not alter the significance or magnitude of the effect sizes.
“However, excluding these studies from analyses did not change the significance and magnitude of the effect sizes.”
Quote in the paperNot a substantial claim - Findingown data
Most included studies enrolled patients with anxiety or depressive disorder, or both.
“(2) Patients with anxiety or depressive disorder, or both, which are frequently associated with FM, were included in most studies.”
Quote in the paperNot a substantial claim - Findingown data
Removing studies with fewer than 20 participants per treatment arm did not change the magnitude and significance of the effect sizes of CBTs on pain, negative mood, and disability at end of treatment.
“Removing studies with <20 participants per treatment arm did not change the magnitude and significance of the effect sizes of CBTs on pain, negative mood and disability at end of treatment”
Quote in the paperNot a substantial claim - Findingown data
CBTs with low reported treatment quality had non-significant effect sizes on pain, negative mood, and disability at end of treatment.
“The effect sizes of CBTs with low reported treatment quality on pain, negative mood and disability at end of treatment were not statistically significant.”
Quote in the paperSubstantial claim - Findingnone given
Studies with 325 participants with a null effect on improvement of health-related quality of life of 20% or greater would have been required to make the result clinically irrelevant (NNTB of 10 or higher).
“Studies with 325 participants with a null effect on improvement of health-related quality of life of 20% or greater would have been required to make the result clinically irrelevant (NNTB of 10 or higher).”
Quote in the paperNot a substantial claim - Interpretationcitation
Therefore, an average pain score reflects an outcome experienced by few patients.
“Consequently, the 'average' pain score represents a result that few patients experience.”
Quote in the paperSubstantial claim - Premisecitation
Recent standards for systematic reviews with meta-analysis of chronic pain randomized controlled trials require reporting of responders.
“Recent standards for systematic reviews with meta-analysis of RCTs in chronic pain require the reports of responders, e.g. the number of patients with a substantial reduction in pain or of health-related quality of life (Moore et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Moore et al., 2010 source
- Premisecitation
Psychological factors contribute to the predisposition, triggering and perpetuation of fibromyalgia syndrome.
“Psychological factors play a major role in the predisposition, triggering and perpetuation of FMS ( € Uc ßeyler et al., 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Üçeyler et al., 2017 source
- Premisecitation
Individual patient data analysis showed that pain responses in chronic pain trials are bimodally rather than normally distributed.
“This recommendation is based on individual patient data analysis which demonstrated that pain responses in chronic pain trials are not normally distributed but have a bimodal distribution.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Moore et al., 2010 source
- Premisecitation
Few studies directly compare guideline-recommended drug therapies with psychological therapies.
“There is still a paucity of studies which directly compare guideline recommended drug therapies and psychological therapies (N€ uesch et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nüesch et al., 2013 source
- Premisecitation
Psychological trials have historically neglected assessment of serious adverse events.
“Assessment of serious adverse events has been neglected by psychological trials in the past (Kashikar-Zuck, 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kashikar-Zuck, 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductown data
Fourteen included studies were rated as having moderate reported treatment quality.
“14 studies had a moderate (Burckhardt et al., 1994;Wigers et al., 1996;Oliver et al., 2001;King et al., 2002;Soares and Grossi, 2002;Williams et al., 2002;Thieme et al., 2003;Redondo et al., 2004;Edinger et al., 2005;Rooks et al., 2007;Falcao et al., 2008;Luciano et al., 2011;Woolfolk et al., 2012;Garcia-Palacios et al., 2015)”
Quote in the paperNot a substantial claim - Study design and conductown data
The remaining included studies were classified as low quality with high overall risk of bias.
“and the remaining studies were low-quality studies (high risk of bias overall) (Burckhardt et al., 1994;Vlaeyen et al., 1996;Wigers et al., 1996;Nicassio et al., 1997;Oliver et al., 2001;Soares and Grossi, 2002;Edinger et al., 2005;Thieme et al., 2006;Castel et al., 2009;Ang et al., 2010;Wicksell et al., 2013;Garcia-Palacios et al., 2015)”
Quote in the paperSubstantial claim - Study design and conductown data
Twelve included studies were rated as having high reported treatment quality.
“and 12 studies had a high reported treatment quality (Kashikar-Zuck et al., 2005;Thieme et al., 2006;Ang et al., 2010;Alda et al., 2011;Mir o et al., 2011;Castel et al., 2012;Kashikar-Zuck et al., 2012;Parra-Delgado and Latorre-Postigo, 2013;Wicksell et al., 2013;Luciano et al., 2014;Mart ınez et al., 2014;Karlsson et al., 2015)”
Quote in the paperNot a substantial claim - Study design and conductown data
Eleven included studies were classified as moderate quality with unclear overall risk of bias.
“11 studies were moderate quality studies (unclear risk of bias overall) (King et al., 2002;Thieme et al., 2003;Redondo et al., 2004;Rooks et al., 2007;Falcao et al., 2008;Kashikar-Zuck et al., 2005;Mir o et al., 2011;Castel et al., 2012;Woolfolk et al., 2012;Parra-Delgado and Latorre-Postigo, 2013;Mart ınez et al., 2014)”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites King et al., 2002
- cites Thieme et al., 2003
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Redondo et al., 2004 source
- Study design and conductown data
Three included studies were rated as having low reported treatment quality.
“Three studies had a low (Vlaeyen et al., 1996;Nicassio et al., 1997;Castel et al., 2009)”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Vlaeyen et al., 1996
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Nicassio et al., 1997
- cites Castel et al., 2009 source
- Interpretationreasoning
The proportion of Caucasians in the whole sample was probably high because most European studies did not report ethnicity.
“The percentage of Caucasians in the whole sample was probably high because most European studies did not report ethnicity of the patients included.”
Quote in the paperNot a substantial claim - Study design and conductown data
The quality of evidence for pain relief of 50% or greater at end of treatment was high.
“The quality of evidence was high.”
Quote in the paperNot a substantial claim - Study design and conductreasoning
In all included studies except one, risk of bias could not be properly assessed because methods were reported incompletely.
“Risk of bias could not be properly assessed in all studies except one (Mir o et al., 2011) due to incomplete method reporting.”
Quote in the paperNot a substantial claim - Interpretationown data
There was no clinically relevant benefit by CBTs for pain relief of 50% or greater at end of treatment according to predefined categories.
“According to the predefined categories there was no clinically relevant benefit by CBTs.”
Quote in the paperSubstantial claim - Interpretationcitation
The review's comparison of cognitive behavioural therapies with best recommended pharmacological therapy agrees with a network meta-analysis that found no efficacy differences between cognitive behavioural therapies and some antidepressants and anticonvulsants for pain and health-related quality of life.
“The results of our comparison of CBTs versus best recommended pharmacological drug therapy is in accordance with the results of a network meta-analysis which found no differences in the efficacy of CBTs compared to some antidepressants and convulsants in reducing pain and improving HRQOL (N€ uesch et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites N€ uesch et al., 2015
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductown data
Some authors of studies conducted after 2010 did not provide requested outcomes that were not reported in this review.
“Even some authors of studies conducted after 2010 did not respond to our requests for outcomes not reported for this review.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Applying the review's results to the entire fibromyalgia population, particularly to male and non-Caucasian patients, is difficult.
“making it difficult to apply the results to the total FM population, especially to male and non-Caucasian patients.”
Quote in the paperSubstantial claim- Rests on an assumption: Treatment effects of cognitive behavioural therapies in fibromyalgia may differ for male and non-Caucasian patients compared with middle-aged Caucasian women.
- Interpretationreasoning
The evidence base for cognitive behavioural therapies in fibromyalgia has strong external validity.
“The applicability (external validity) of evidence is strong for the following reasons.”
Quote in the paperSubstantial claim - Interpretationcitation
Those previous conclusions agree with a recent overview of systematic reviews of cognitive behavioural therapies in fibromyalgia.
“and concur with the ones of a recent overveiw of systematic reviews of CBTs in FMS (K€ ollner et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites K€ ollner et al., 2017
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductreasoning
The methodological and treatment quality of some included studies might have been underestimated because some details needed for risk-of-bias and treatment-quality scores were not reported.
“We might have underestimated the methodological and treatment quality of some studies which might not have reported some details required for the risk of bias and treatment quality scores used.”
Quote in the paperNot a substantial claim - Interpretationcitation
The review's results align with a recent systematic review that found acceptance and commitment therapy superior to controls for pain acceptance and reducing negative mood.
“Our results are in line with a recent systematic review which demonstrated that acceptance and commitment therapy is superior to controls (no therapy, therapy as usual) in pain acceptance and in reducing negative mood (Hughes et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hughes et al., 2017 source
- Study design and conductnone given
The review cannot be certain that unpublished studies with positive or negative results were not missed.
“We cannot be certain that other studies that have not been published (with positive or negative results) were not identified.”
Quote in the paperNot a substantial claim
- Classified as probably not a substantial claim. 61
- May combine two claims. 39
- The quote only partly states this claim. 26
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataCognitive behavioural therapy was delivered in groups only in most studies, except three that combined individual and group sessions and one that used single-person therapy.
“CBTs were delivered by all studies in groups only except three studies which combined individual and group sessions (Soares and Grossi, 2002;Kashikar-Zuck et al., 2005;Garcia-Palacios et al., 2015) and one study with single person therapy (Kashikar-Zuck et al., 2012).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites Soares and Grossi, 2002 source
- cites Kashikar-Zuck et al., 2005
- cites Garcia-Palacios et al., 2015 source
The Treatment section (page unavailable) describes Garcia-Palacios et al.’s intervention as a group CBT program comprising six two-hour group sessions. It does not describe combined individual and group therapy for this study, contrary to the citing sentence’s classification. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOne of the excluded Internet-delivered studies had been in the first version of the review.
“One of these studies was included in the first version of the review (Williams et al., 2010).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Williams et al., 2010 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFibromyalgia syndrome is a clinically defined chronic condition marked by widespread pain, sleep disturbance, cognitive dysfunction and fatigue.
“Fibromyalgia syndrome (FMS) is a clinically defined chronic condition characterized by chronic widespread pain, sleep disturbances, cognitive dysfunction and fatigue (Wolfe et al., 2011).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Wolfe et al., 2011 source
Classified as probably not a substantial claim.
PremisereasoningDespite existing research and guidelines, several major questions about the importance of cognitive behavioural therapies in fibromyalgia syndrome remain unresolved.
“Despite a large amount of research and recommendations for the management of FMS by recent evidence-based guidelines (K€ ollner et al.,2017;MacFarlane et al., 2017) some major questions on the importance of CBTs in FMS are not definitely answered:”
Quote in the paperSubstantial claim1 of 2 sources checked- cites K€ ollner et al.,2017
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites MacFarlane et al., 2017 source
The Cognitive behavioural therapies section reviews multiple trials, and the EULAR revised recommendations section gives CBT a weak recommendation. The Research priorities section identifies unresolved questions about treatment combinations and who responds to specific therapies, but does not identify the importance of CBT itself as an unanswered major question. No page numbers are available in our copy. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Rests on an assumption: No study has compared the efficacy of different cognitive behavioural therapy types in fibromyalgia syndrome.
- Rests on an assumption: Whether assessment and reporting of adverse events in cognitive behavioural therapy trials for fibromyalgia syndrome has improved in recent years has not been studied.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataTwo studies were excluded because cognitive behavioural therapy was delivered over the Internet without contact with a psychotherapist.
“We excluded two studies because CBTs were delivered by Internet without any contact with a psychotherapist (Williams et al., 2010;Menga et al., 2014).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Williams et al., 2010 source
- cites Menga et al., 2014
Classified as probably not a substantial claim.
InterpretationcitationBlinding of participants and personnel was not assessed because therapists and patients cannot be blinded to treatment delivery or receipt.
“We excluded the option of 'blinding participants and personnel' because neither therapists nor patients can be blinded to whether they deliver or receive treatment (Williams et al., 2012).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Williams et al., 2012 source
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationOne study did not report number and duration of sessions.
“One study did not report the number and duration of sessions (Woolfolk et al., 2012).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Woolfolk et al., 2012 source
The Study Design section (2.1; page unavailable) explicitly reports 10 weekly ACBT sessions, so the claim that the number was not reported is incorrect. The retrieved treatment descriptions do not specify how long each individual session lasted, supporting only the duration portion of the claim. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationCognitive behavioural therapy approaches may be more acceptable and easier to implement in Western individualist cultures.
“CBTs approaches may be more acceptable and easier to implement in western populations whose cultures are 'individualist' (where individual self-realization is everything and relationships with family and others are subordinate)”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Naeem et al., 2015 source
May combine two claims.
InterpretationcitationCognitive behavioural therapy approaches may be less acceptable and harder to integrate into daily life for patients from collectivist cultures.
“and less acceptable and more difficult to incorporate into daily lives in patients from 'collectivist' cultures (where networks, kinship and the roles they bring are very important and goals are pursued within those constraints) (Naeem et al., 2015).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Naeem et al., 2015 source
Classified as probably not a substantial claim.
Interpretationown dataThe review's analyses of methodological problems in most included studies support the position that no new trials should be conducted until those critical problems are addressed.
“Our analyses of the methodology problems of most of the studies analysed in this review supports their postulation, that there should be no new trials until these critical problems are addressed (Eccleston and Crombez, 2017).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Eccleston and Crombez, 2017 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataTwenty-two studies from the first version were included.
“We included 22 studies from the first version of the review”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSeven new studies were included.
“We included seven new studies (Williams et al., 2002;Parra-Delgado and Latorre-Postigo, 2013;Wicksell et al., 2013;Luciano et al., 2014;Mart ınez et al., 2014;Garcia-Palacios et al., 2015;Karlsson et al., 2015).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe updated search yielded 561 hits.
“The updated search produced 561 hits.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe new studies added 546 participants.
“These studies added 546 new participants.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenOne study (Williams et al., 2002) was not in the first version of the review.
“One study (Williams et al., 2002) was not included in the first version of this review.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Williams et al., 2002
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataMedian number of sessions was 10 (range 6-60) and median total hours was 18 (range 3-102).
“The median number of sessions was 10 (6-60) and the median total hours was 18 (3-102) h.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataCBTs were statistically significantly superior to controls for pain relief of 50% or greater at long-term follow-up (p<0.0001).
“CBTs were statistically significant superior to controls (p-value < 0.0001).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataEighteen included studies were conducted in Europe.
“Eighteen studies were conducted in Europe”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataThere was no statistically significant difference between CBTs and controls for improvement of health-related quality of life of 20% or greater at long-term follow-up (p=0.08).
“There was no statistically significant difference between CBTs and controls (p-value 0.08).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationAll included studies except one were outpatient-based.
“All studies but one (Thieme et al., 2003) were outpatient-based.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Thieme et al., 2003 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMedian cognitive behavioural therapy duration was 10 weeks (range 3-54).
“The median duration of all CBTs was 10 (3-54) weeks.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationTwo studies included only children and adolescents; the remaining studies included only adults.
“Two studies included only children and adolescents (Kashikar-Zuck et al., 2005;Kashikar-Zuck et al., 2012); the other studies included only adults.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kashikar-Zuck et al., 2005
- cites Kashikar-Zuck et al., 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationDisease duration in children and adolescents was reported as 3 years in one study.
“Disease duration in children and adolescents was reported to be 3 years in one study (Kashikar-Zuck et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kashikar-Zuck et al., 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataFifteen studies included only women.
“Fifteen studies included only women”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataCBTs were statistically significantly superior to controls for reduction in disability at end of treatment (p=0.007).
“CBTs were statistically significantly superior to controls (p-value 0.007).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataOverall, included patients had long disease duration (more than five years) except in three studies reporting less than five years.
“Overall, the studies included patients with a long disease duration (more than five years) except in three studies (Soares and Grossi, 2002;Falcao et al., 2008;Mir o et al., 2011) which reported a disease duration of <5 years.”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataMedian participants per cognitive behavioural therapy group was 32 (range 14-207) and per control group was 30.
“The median number of participants in CBTs groups was 32 (14-207), in controls 30 .”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataCBTs were statistically significantly superior to controls for reduction in negative mood at end of treatment (p<0.0001).
“CBTs were statistically significantly superior to controls (p-value < 0.0001).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingcitationOne study used a cross-over design; the rest used a parallel design.
“One study used a cross-over design (Kashikar-Zuck et al., 2005), the remaining studies used a parallel design.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kashikar-Zuck et al., 2005
The quote only partly states this claim.
Findingown dataCBTs were statistically significantly superior to controls for reduction in negative mood at long-term follow-up (p=0.0008).
“CBTs were statistically significantly superior to controls (p-value 0.0008).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataCBTs were statistically significantly superior to controls for improvement of health-related quality of life of 20% or greater at end of treatment (p=0.04).
“CBTs were statistically significantly superior to controls (pvalue 0.04).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataCBTs were statistically significantly superior to controls for reduction in fatigue at end of treatment (p=0.02).
“CBTs were statistically significant superior to controls (p-value 0.02).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataThe standardized mean difference for reduction in negative mood at long-term follow-up was -0.48 (95% CI -0.77 to -0.20).
“SMD was À0.48 (95% CI À0.77 to À0.20).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataTen of the European studies were conducted in Spain.
“of which 10 were conducted in Spain”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSix studies used active non-pharmacological controls.
“six studies with active non-pharmacological controls”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataCBTs were statistically significantly superior to controls for reduction in disability at long-term follow-up (p=0.0001).
“CBTs were statistically significant superior to controls (p-value 0.0001).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe analysis included 1236 participants in treatment groups and 1246 in control groups.
“We included a total of 1236 participants in treatment groups and 1246 participants in control groups in the analysis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingreasoningThe remaining studies compared cognitive behavioural therapy with treatment as usual.
“the remaining studies compared CBTs to treatment as usual.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMedian attended cognitive behavioural therapy sessions was 77% (range 42-93%).
“The median of attended CBTs sessions was 77% (range 42-93%).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataTwenty-three studies provided traditional cognitive behavioural therapy.
“Twenty-three studies provided traditional CBT”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMedian percentage of women in cognitive behavioural therapy groups was 100% (range 89-100%).
“The median percentage of women in CBTs groups was 100% (89-100%).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAll studies except six were single-centre.
“All studies except six (Oliver et al., 2001;Rooks et al., 2007;Alda et al., 2011;Luciano et al., 2011Luciano et al., , 2014;;Kashikar-Zuck et al., 2012) were single-centre studies.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataCBTs were statistically significantly superior to controls for pain relief of 50% or greater at end of treatment (p=0.0003).
“CBTs were statistically significantly superior to controls (p-value 0.0003).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataFourteen studies reported average attendance rates.
“Fourteen studies reported on average attendance rates of participants”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThree studies offered acceptance or mindfulness-based therapy.
“three studies offered acceptance/mindfulness-based therapy”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataTen studies were conducted in North America (USA) and one in South America (Brazil).
“Ten studies were conducted in North America (USA) (Nicassio et al., 1997;Oliver et al., 2001;King et al., 2002;Williams et al., 2002;Edinger et al., 2005;Kashikar-Zuck et al., 2005, 2012;Rooks et al., 2007;Ang et al., 2010;Woolfolk et al., 2012) and one in South America (Brazil) (Falcao et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Falcao et al., 2008 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingcitationTwo studies each provided self-management education and operant therapy.
“two studies each provided self management education (Oliver et al., 2001;Rooks et al., 2007) and operant therapy (Thieme et al., 2003(Thieme et al., , 2006)).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Oliver et al., 2001
- cites Rooks et al., 2007
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Thieme et al., 2003 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingcitationAll studies used live face-to-face contact except one delivered by telephone.
“All studies were conducted by live face-toface contact except one study which was delivered by telephone (voice-to-voice) (Ang et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ang et al., 2010 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataOnly one study had total treatment time below 5 h and seven had more than 25 h.
“Only one study had a total treatment time <5 h (Ang et al., 2010) and seven studies had a treatment time of >25 h (Wigers et al., 1996;Soares and Grossi, 2002;Thieme et al., 2003;Thieme et al., 2006;Falcao et al., 2008;Castel et al., 2012;Karlsson et al., 2015).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataFive studies used attention controls.
“five studies with attention controls”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMedian mean age was 47.4 years (range 15.2-55.4).
“The median of the mean age was 47.4 (15.2-55.4)years.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataEighteen studies performed follow-ups at 6 months or longer.
“Eighteen studies performed follow-ups at equal to or greater than 6 months”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAt end of treatment, long-term CBTs had non-significant effect sizes on pain and disability, and a moderate significant effect on negative mood.
“At end of treatment, the effect sizes of long-term CBTs on pain and disability were not statistically significant, the effect size on negative mood was moderate and statistically significant.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCBTs were superior to controls in pain relief of 50% or greater and reducing negative mood and disability at long-term follow-up.
“and in pain relief of 50% or greater and in reducing negative mood and disability at long-term follow-up.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCBTs with high reported treatment quality had small significant effects on disability and pain, and a moderate significant effect on mood at end of treatment.
“The effect sizes of CBTs with high reported treatment quality on disability and pain at end of treatment were small and statistically significant, the effect size on mood at end of treatment was moderate and statistically significant”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCBTs did not differ in efficacy except superiority for coping with pain from recommended drug therapy (pregabalin and/or duloxetine) at the end of treatment and at long-term follow-up.
“CBTs did not differ in efficacy except superiority for coping with pain from recommended drug therapy (pregabalin and/or duloxetine) at the end of treatment and at long-term follow-up.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt long-term follow-up, long-term CBTs had large significant effects on negative mood and disability, and a medium significant effect on pain.
“At long-term followup, the effect sizes of long-term CBTs on negative mood and disability were large and statistically significant and on pain medium and statistically significant.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCBTs with moderate reported treatment quality had small significant effects on negative mood and disability, and a non-significant effect on pain at end of treatment.
“The effect sizes of CBTs with moderate reported treatment quality on negative mood and disability at end of treatment were small and statistically significant, the effect size on pain was not statistically significant.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataCBTs were statistically significantly superior to controls for reduction in fatigue at long-term follow-up (p=0.0005).
“CBTs were statistically significant superior to controls (p-value 0.0005).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn children and adolescents, traditional CBT had a small significant effect on mean pain intensity at end of treatment, and non-significant effects on negative mood and disability.
“The effect size of traditional CBT on mean pain intensity at end of treatment in children and adolescents was small and statistically significant.The effect sizes on negative mood and disability at end of treatment were not statistically significant.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAt long-term follow-up, short-term CBTs had non-significant effects on negative mood and disability, and a small significant effect on pain.
“At long-term follow-up, the effect sizes of short-term CBTs on negative mood and disability were not statistically significant.The effect size on pain was small and statistically significant”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt long-term follow-up, operant therapy was superior to traditional CBTs in improvement of HRQOL of 20% or greater, reduction in disability, negative mood, pain relief 30% or greater, and coping with pain.
“Operant therapy was superior to traditional CBTs in improvement of HRQOL of 20% or greater (p-value 0.007), reduction in disability (p-value 0.008), of negative mood (p-value 0.005), in pain relief 30% or greater (p-value 0.009) and coping with pain (p-value 0.05).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCBTs were superior to controls in pain relief of 50% or greater, improving health-related quality of life of 20% or greater, and reducing negative mood and disability at the end of treatment.
“CBTs were superior to controls (waiting list, attention control, treatment as usual, other active nonpharmacological therapies) in pain relief of 50% or greater, in improving of health-related quality of life of 20% or greater and in reducing negative mood and disability at the end of treatment”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Findingnone givenThe updated review included three studies using acceptance-based approaches.
“Our updated review could include three studies with acceptance-based approaches.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataThe standardized mean difference for reduction in fatigue at long-term follow-up was -0.42 (95% CI -0.65 to -0.18).
“SMD was À0.42 (95% CI À0.65 to À0.18).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt end of treatment, short-term CBTs had small significant effects on negative mood and disability, and a non-significant effect on pain.
“At end of treatment, the effect sizes of short-term CBTs on negative mood and disability were small and statistically significant, the effect size on pain was not statistically significant.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn adults, traditional CBT had small significant effects on mean pain intensity, negative mood, and disability at end of treatment.
“The effect sizes of traditional CBT on mean pain intensity, negative mood and disability in adults at end of treatment were small and statistically significant”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataTwo reviewers independently extracted study data using a purpose-designed extraction form.
“Two authors extracted data on the studies (including the methods, settings, participants, interventions, outcomes, results, funding, conflicts of interest) independently using a specially designed data extraction form (KB, WH).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataTwo reviewers independently classified each study's cognitive behavioural therapy type.
“The classification of the CBT delivered by the studies into self-management, traditional CBT, operant therapy and acceptance-based CBTs was rated independently by two authors (KB, WH) based on the details of therapy as reported by the authors and on the classification of CBTs as outlined in TYPES OF INTERVENTION.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAcceptance and commitment therapy has strong research support for chronic or persistent pain according to Division 12 of the American Psychological Association.
“Acceptance and commitment therapy (ACT) received strong research support for chronic/ persistent pain by the Division 12 of the American Psychological Association (Society of Clinical Psychology, 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Society of Clinical Psychology, 2017
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataTwo reviewers independently rated reported treatment quality.
“Reported treatment quality was rated independently by two authors (KB, WH).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataOne reviewer entered data into RevMan 5.3 and a second reviewer validated the entries.
“One author (WH) entered data into Review Manager (RevMan) 5.3 (RevMan, 2014), and a second author (KB) validated the entries.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites RevMan, 2014
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim.
Study design and conductown dataTwo reviewers independently assessed risk of bias for each included trial.
“Two review authors (KB, WH) independently assessed the risk of bias of each included trial.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is no universally accepted definition of which techniques constitute cognitive behavioural therapy.
“However, there is no universally accepted definition of which techniques constitute CBT (Morley, 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Morley, 2011 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenDisagreements were resolved by discussion, with a third reviewer consulted if needed.
“We resolved disagreements by discussion, if necessary a third review author (PW) was consulted.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCognitive behavioural therapies are considered the gold-standard psychological treatment for fibromyalgia patients by Division 12 of the American Psychological Association.
“CBTs are the 'gold-standard' psychological treatment for FM patients according to the Division 12 of the American Psychological Association (Society of Clinical Psychology, 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Society of Clinical Psychology, 2017
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataTwo reviewers independently screened titles and abstracts and selected studies using inclusion and exclusion criteria.
“Two review authors (KB, WH) independently scrutinized all the titles and abstracts and selected studies based on inclusion and exclusion criteria.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationTreatment quality was assessed with a five-criteria scale designed for psychological pain treatment studies.
“We assessed the quality of the treatment using five criteria (treatment content and setting, treatment duration, manualization of the treatment, adherence of the therapist to the manual, therapist training and client engagement) on a quality rating scale designed specifically for application to psychological treatment studies in pain.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yates et al., 2005 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenRisk-of-bias disagreements were resolved by discussion and consensus, with a third reviewer as arbiter if needed.
“Disagreements were resolved by discussion and consensus, otherwise a third review author (PW) acted as arbiter.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningPsychological therapies may reduce key symptoms and improve daily functioning in fibromyalgia syndrome.
“Therefore, psychological therapies may help to reduce key symptoms and improve daily functioning.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationThe label cognitive behavioural therapies includes classical and operant therapies, psychoeducation, different cognitive behavioural therapies and acceptance-based therapies.
“Within the label 'CBTs', 'classical', operant therapies, psychoeducation, different types of cognitive behavioural therapies and acceptance-based therapies are included (Kaiser and Nilges, 2015).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kaiser and Nilges, 2015 source
Classified as probably not a substantial claim.
PremisecitationA prior systematic review found that higher treatment dose was associated with better outcome.
“One systematic review found that higher treatment dose was associated with better outcome (Glombiewski et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Glombiewski et al., 2010 source
The quote only partly states this claim.
Study design and conductown dataThe quality of evidence for improvement of health-related quality of life of 20% or greater at long-term follow-up was moderate, downgraded by one level due to inconsistency.
“The quality of evidence was downgraded by one level to moderate because of inconsistency.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Interpretationown dataThe effect size for reduction in fatigue at end of treatment was small and there was a clinically relevant benefit by CBTs.
“According to the predefined categories, the effect size was small and there was a clinically relevant benefit by CBTs.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Study design and conductown dataThe quality of evidence for improvement of health-related quality of life of 20% or greater at end of treatment was moderate, downgraded by one level due to inconsistency.
“The quality of evidence was downgraded by one level to moderate because of inconsistency.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Interpretationown dataThere was a clinically relevant benefit by CBTs for improvement of health-related quality of life of 20% or greater at end of treatment according to predefined categories.
“According to the predefined categories there was a clinically relevant benefit by CBTs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).
Study design and conductnone givenThe quality of evidence for reduction in negative mood at end of treatment was high.
“The quality of evidence was high.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe effect size for reduction in negative mood at end of treatment was small and there was a clinically relevant benefit by CBTs.
“According to the predefined categories, the effect size was small and there was a clinically relevant benefit by CBTs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).
Study design and conductnone givenThe quality of evidence for reduction in fatigue at end of treatment was high.
“The quality of evidence was high.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).
Study design and conductnone givenThe quality of evidence for acceptability at end of treatment was high.
“The quality of evidence was high.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Interpretationown dataThere was no clinically relevant benefit by CBTs for pain relief of 50% or greater at long-term follow-up according to predefined categories.
“According to the predefined categories there was no clinically relevant benefit by CBTs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). The quote only partly states this claim.
Study design and conductown dataThe quality of evidence for pain relief of 50% or greater at long-term follow-up was high.
“The quality of evidence was high.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based). The quote only partly states this claim.
Study design and conductown dataThe quality of evidence for reduction in negative mood at long-term follow-up was moderate, downgraded by one level due to inconsistency.
“The quality of evidence was downgraded by one level to moderate because of inconsistency.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).
Study design and conductnone givenThe quality of evidence for reduction in disability at end of treatment was high.
“The quality of evidence was high.”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
Interpretationown dataThe effect size for reduction in disability at end of treatment was small and there was a clinically relevant benefit by CBTs.
“According to the predefined categories, the effect size was small and there was a clinically relevant benefit by CBTs.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Study design and conductown dataThe quality of evidence for safety at end of treatment was moderate, downgraded by one level due to low event rate.
“The quality of evidence was moderate downgraded by one level due to low event rate.”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
Interpretationown dataThe effect size for reduction in negative mood at long-term follow-up was small and there was a clinically relevant benefit by CBTs.
“According to the predefined categories, the effect size was small and there was a clinically relevant benefit by CBTs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenMore intensive therapies, up to 75 hours, might improve long-term outcomes.
“More intensive therapies (up to 75 h) might improve long-term outcomes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).
Study design and conductnone givenThe quality of evidence for reduction in fatigue at long-term follow-up was high.
“The quality of evidence was high.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataSubgroup analyses demonstrated that reductions in mean pain intensity, negative mood, and disability were detectable for traditional CBTs and acceptance-based CBTs at end of treatment and at long-term follow-up, and for operant therapy at follow-up, but not for operant therapy or self-management education programs at end of treatment if compared to nonpharmacological controls.
“Subgroup analyses demonstrated that a reduction in mean pain intensity, negative mood and disability were detectable for traditional CBTs and acceptancebased CBTs at end of treatment and at long-term follow-up and for operant therapy at follow-up, but not for operant therapy or self management education programs at end of treatment if compared to nonpharmacological controls.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductreasoningThe review used only reported data for quality assessment and did not request further details from authors in order to avoid response bias.
“We relied on the reported data for quality assessment and did not ask authors for further details because we did not want to introduce a 'response' bias.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Requesting further details from study authors would introduce response bias.
May combine two claims. The quote only partly states this claim.
Interpretationown dataThe effect size for reduction in fatigue at long-term follow-up was small and there was a clinically relevant benefit by CBTs.
“According to the predefined categories, the effect size was small and there was a clinically relevant benefit by CBTs.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Interpretationown dataThe effect size for reduction in disability at long-term follow-up was moderate and there was a clinically relevant benefit by CBTs.
“According to the predefined categories, the effect size was moderate and there was a clinically relevant benefit by CBTs.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Study design and conductown dataThe quality of evidence for reduction in disability at long-term follow-up was moderate, downgraded by one level due to inconsistency.
“The quality of evidence was downgraded by one level to moderate because of inconsistency.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
No study has compared the efficacy of different cognitive behavioural therapy types in fibromyalgia syndrome.
“If one type of CBTs is superior in terms of efficacy in FMS has not been studied to our knowledge.”
The paper relies on this without support.
Whether assessment and reporting of adverse events in cognitive behavioural therapy trials for fibromyalgia syndrome has improved in recent years has not been studied.
“If the assessment and reporting of adverse events in CBTs trials of FMS has improved in the last years, has not been studied”
The paper relies on this without support.
Cognitive behavioural therapies are the dominant contemporary psychological treatments for chronic pain.
“Cognitive behavioural therapies (CBTs) are the dominant contemporary psychological treatments for chronic pain.”
The authors state this as an assumption.
Methodological differences across studies explain the considerable heterogeneity observed.
“We assume methodological difference across studies for this considerable heterogeneity.”
The paper relies on this without support.
Treatment effects of cognitive behavioural therapies in fibromyalgia may differ for male and non-Caucasian patients compared with middle-aged Caucasian women.
“However, the majority of the participants were middle-aged Caucasian women, making it difficult to apply the results to the total FM population, especially to male and non-Caucasian patients.”
The authors state this as an assumption.
Requesting further details from study authors would introduce response bias.
“We relied on the reported data for quality assessment and did not ask authors for further details because we did not want to introduce a 'response' bias.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The number of clinical trials assessing possible benefits of ACT for chronic pain has increased in the last decade, producing a plethora of systematic reviews on this topic during the last 5 years.
“The number of clinical trials assessing the possible benefits of ACT for chronic pain has in creased in the last decade, producing, in turn, a ple thora of systematic reviews on this topic during the last 5 years.”
From Acceptance and Commitment Therapy for Chronic Pain: An Overview of Systematic Reviews with Meta-Analysis of Randomized Clinical Trials (2024) · cites this paper as [4]
The study table (section 4.6.1; page not specified) lists ACT trials from 2013 and 2014, and the References list a 2017 systematic review of ACT for chronic pain. The paper does not establish that ACT trial numbers increased over the preceding decade or that they produced a plethora of systematic reviews in the preceding five years. (LLM, conf=0.76)
Experimental — accuracy not yet measuredThese results correspond to another recent systematic review analyzing the effects of CBTs, including ACT and MBCT, on FM.
“These results correspond to another recent systematic review analyzing the effects of CBTs, including ACT and MBCT, on FM [17].”
From Mindfulness- And acceptance-based interventions for patients with fibromyalgia - A systematic review and meta-analyses (2019) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
The stated number of attention-control studies differs from the list
MinorThe paper says five studies used attention controls but names six distinct studies in the accompanying list.
“five studies with attention controls (Vlaeyen et al., 1996;Nicassio et al., 1997;Soares and Grossi, 2002;Thieme et al., 2006;Mir o et al., 2011;Mart ınez et al., 2014)”
“five studies compared with waiting list controls (Burckhardt et al., 1994;King et al., 2002;Wicksell et al., 2013;Luciano et al., 2014;Karlsson et al., 2015)”
A study is described as both new and previously included
MinorWilliams et al. (2002) appears among the seven new studies, but the paper also lists it among the 22 studies retained from the first review.
“We included seven new studies (Williams et al., 2002;Parra-Delgado and Latorre-Postigo, 2013;Wicksell et al., 2013;Luciano et al., 2014;Mart ınez et al., 2014;Garcia-Palacios et al., 2015;Karlsson et al., 2015).”
“We included 22 studies from the first version of the review (Burckhardt et al., 1994;Vlaeyen et al., 1996;Wigers et al., 1996;Nicassio et al., 1997;Oliver et al., 2001;King et al., 2002;Soares and Grossi, 2002;Williams et al., 2002;Thieme et al., 2003”
The stated number of active-control studies differs from the list
MinorThe paper says six studies used active non-pharmacological controls but names only five distinct studies.
“six studies with active non-pharmacological controls (Thieme et al., 2003;Redondo et al., 2004;Kashikar-Zuck et al., 2005;Rooks et al., 2007;Kashikar-Zuck et al., 2012)”
“five studies with attention controls (Vlaeyen et al., 1996;Nicassio et al., 1997;Soares and Grossi, 2002;Thieme et al., 2006;Mir o et al., 2011;Mart ınez et al., 2014)”
Williams 2002 is both new and previously included
MinorThe paper says Williams et al. (2002) was absent from the first review, but also lists it among the studies retained from that review.
“One study (Williams et al., 2002) was not included in the first version of this review.”
“We included 22 studies from the first version of the review (Burckhardt et al., 1994;Vlaeyen et al., 1996;Wigers et al., 1996;Nicassio et al., 1997;Oliver et al., 2001;King et al., 2002;Soares and Grossi, 2002;Williams et al., 2002;”
Reported treatment-time range excludes a table entry
MinorThe stated maximum total treatment time is 102 hours, but the table gives Soares and Grossi (2002) a total treatment time of 120 hours.
“the median total hours was 18 (3-102) h.”
“| Soares and Grossi (2002) a Sweden | CBT | Attention control | 10 | 10 | 18 | | | | | | | | | 120 | 100 | |”
Attention-control study count does not match its list
MinorThe text says five studies used attention controls but names six: Vlaeyen, Nicassio, Soares and Grossi, Thieme, Miró, and Martínez.
“five studies with attention controls”
“(Vlaeyen et al., 1996;Nicassio et al., 1997;Soares and Grossi, 2002;Thieme et al., 2006;Mir o et al., 2011;Mart ınez et al., 2014)”
Updated-search counts disagree
MinorThe narrative reports 561 hits from the updated search, whereas the flow diagram reports 762 database records for 2013-2017.
“The updated search produced 561 hits.”
“762 records identified through database searching 2013-2017”
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,588 · see citing works
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · see citing works
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554 · see citing works
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575 · see citing works
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563 · see citing works
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329 · see citing works
Wolfe, F., Clauw, D. J., Fitzcharles, M., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010) · Arthritis Care & Research · doi:10.1002/acr.20140 · Cited by 3,952 · see citing works
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000251 · Cited by 2,296 · see citing works
Psychological therapies for the management of chronic pain (excluding headache) in adults
Williams, A. C. D. C., Eccleston, C., & Morley, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007407.pub3 · Cited by 1,634 · see citing works
Behavioral methods for chronic pain and illness
Fordyce, W. E. (1977) · Pain · doi:10.1016/0304-3959(77)90029-x · Cited by 1,630 · see citing works
EULAR revised recommendations for the management of fibromyalgia
Macfarlane, G. J., Kronisch, C., Dean, L. E., Atzeni, F., Häuser, W., Fluß, E., Choy, E., Kosek, E., Amris, K., Branco, J., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209724 · Cited by 1,566 · see citing works
Self-citationWOLFE, F., CLAUW, D. J., FITZCHARLES, M.-A., GOLDENBERG, D. L., HÄUSER, W., KATZ, R. S., MEASE, P., RUSSELL, A. S., RUSSELL, I. J., & WINFIELD, J. B. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100594 · Cited by 1,499 · see citing works
Self-citationPrimary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls
Yunus, M., Masi, A. T., Calabro, J. J., Miller, K. A., & Feigenbaum, S. L. (1981) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(81)90096-2 · Cited by 910 · see citing works
Behavioral Methods for Chronic Pain and Illness
Quimby, C. W. (1976) · Anesthesiology · doi:10.1097/00000542-197610000-00030 · Cited by 866 · see citing works
Veehof, M. M., Trompetter, H. R., Bohlmeijer, E. T., & Schreurs, K. M. G. (2016) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2015.1098724 · Cited by 737 · cited 1× · see citing works
“…techniques (e.g. mindfulness meditation training) to facilitate a separation between ‘self’ and one’s thoughts, feelings and pain experience, and encourage patients to base their actions on their most important values as opposed to their immediate feelings, thoughts and pain (Veehof et al., 2016).”
BackgroundAcceptance and Commitment Therapy (ACT) for Chronic Pain: A Systematic Review and Meta-Analyses
Hughes, L. S., Clark, J., Colclough, J. A., Dale, E., & McMillan, D. (2017) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000000425 · Cited by 611 · see citing works
Häuser, W., Ablin, J., Fitzcharles, M.-A., Littlejohn, G., Luciano, J. V., Usui, C., & Walitt, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.22 · Cited by 505 · see citing works
Self-citationBurckhardt, C. S., Mannerkorpi, K., Hedenberg, L., & BJELLE, A. O. (1994) · PubMed · Cited by 393 · see citing works
“Evidence” in chronic pain–establishing best practice in the reporting of systematic reviews
Moore, A. R., Eccleston, C., Derry, S., Wiffen, P., Bell, R. F., Straube, S., & McQuay, H. (2010) · Pain · doi:10.1016/j.pain.2010.05.011 · Cited by 370 · see citing works
Psychological treatments for fibromyalgia: A meta-analysis
Glombiewski, J. A., Sawyer, A. T., Gutermann, J., Koenig, K., Rief, W., & Hofmann, S. G. (2010) · Pain · doi:10.1016/j.pain.2010.06.011 · Cited by 341 · see citing works
Behavioral Insomnia Therapy for Fibromyalgia Patients: A Randomized Clinical Trial
Edinger, J. D., Wohlgemuth, W. K., Krystal, A. D., & Rice, J. R. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2527 · Cited by 330 · see citing works
Effects of Aerobic Exercise Versus Stress Management Treatment in Fibromyalgia
Wigers, S. H., Stiles, T. C., & Vogel, P. A. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609069212 · Cited by 328 · see citing works
Cognitive behavioural therapies for fibromyalgia
Bernardy, K., Klose, P., Busch, A. J., Choy, E. H., & Häuser, W. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009796.pub2 · Cited by 272 · see citing works
Self-citationArthritis self‐management education programs: A meta‐analysis of the effect on pain and disability
Warsi, A., LaValley, M. P., Wang, P. S., Avorn, J., & Solomon, D. H. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11210 · Cited by 270 · see citing works
Acceptance and commitment therapy for fibromyalgia: A randomized controlled trial.
Wicksell, R. K., Kemani, M., Jensen, K., Kosek, E., Kadetoff, D., Sorjonen, K., Ingvar, M., & Olsson, G. L. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00224.x · Cited by 244 · cited 11× · see citing works
“…et al., 2004; Castel et al., 2009, 2012; Alda et al., 2011; Luciano et al., 2011, 2014; Mir o et al., 2011; Parra-Delgado and Latorre-Postigo, 2013; Wicksell et al., 2013; Mart ınez et al., 2014; Garcia-Palacios et al., 2015; Karlsson et al., 2015), of which 10 were conducted in Spain (Redondo et…”
BackgroundMethodResultInfluential(1996) · PubMed · Cited by 234 · see citing works
Redondo, J. R., Justo, C. M., Moraleda, F. V., Velayos, Y. G., Puche, J. J. O., Zubero, J. R., Hernández, T. G., Ortells, L. C., & Pareja, M. Á. V. (2004) · Arthritis Care & Research · doi:10.1002/art.20252 · Cited by 229 · see citing works
Nüesch, E., Häuser, W., Bernardy, K., Barth, J., & Jüni, P. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201249 · Cited by 225 · see citing works
Self-citationRooks, D. S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.20.2192 · Cited by 219 · see citing works
Internet-enhanced management of fibromyalgia: A randomized controlled trial
Williams, D. A., Kuper, D., Segar, M., Mohan, N., Sheth, M., & Clauw, D. J. (2010) · Pain · doi:10.1016/j.pain.2010.08.034 · Cited by 210 · see citing works
(1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-4-545_1 · Cited by 193 · see citing works
Psychosocial approaches to pain management: an organizational framework
Jensen, M. P. (2011) · Pain · doi:10.1016/j.pain.2010.09.002 · Cited by 191 · see citing works
Kashikar‐Zuck, S., Ting, T. V., Arnold, L. M., Bean, J. A., Powers, S. W., Graham, T. B., Passo, M. H., Schikler, K. N., Hashkes, P. J., Spalding, S. J., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30644 · Cited by 186 · see citing works
Luciano, J. V., Guallar, J. A., Aguado, J., López-del-Hoyo, Y., Olivan, B., Magallón, R., Alda, M., Serrano-Blanco, A., Gili, M., & Garcia-Campayo, J. (2014) · PAIN · doi:10.1016/j.pain.2013.12.029 · Cited by 183 · see citing works
Operant behavioral treatment of fibromyalgia: a controlled study
Thieme, K., Gromnica‐Ihle, E., & Flor, H. (2003) · Arthritis Care & Research · doi:10.1002/art.11124 · Cited by 181 · see citing works
Long‐term cyclophosphamide therapy in rheumatoid arthritis
Fosdick, W. M., Parsons, J. L., & Hill, D. F. (1968) · Arthritis & Rheumatism · doi:10.1002/art.1780110205 · Cited by 177 · see citing works
(2002) · PubMed · Cited by 176 · see citing works
Morley, S. (2011) · Pain · doi:10.1016/j.pain.2010.10.042 · Cited by 172 · see citing works
Thieme, K., Flor, H., & Turk, D. C. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2010 · Cited by 167 · see citing works
(2002) · PubMed · Cited by 167 · see citing works
Martínez, M. P., Miró, E., Sánchez, A. I., Díaz-Piedra, C., Cáliz, R., Vlaeyen, J. W. S., & Buela-Casal, G. (2014) · Journal of Behavioral Medicine · doi:10.1007/s10865-013-9520-y · Cited by 161 · see citing works
A scale for rating the quality of psychological trials for pain
Yates, S. L., Morley, S., Eccleston, C., & de C. Williams, A. C. (2005) · Pain · doi:10.1016/j.pain.2005.06.018 · Cited by 150 · see citing works
(1997) · PubMed · Cited by 149 · see citing works
(2005) · PubMed · Cited by 126 · see citing works
Multimodal pain therapy in chronic noncancer pain—gold standard or need for further clarification?
Kaiser, U., Treede, R., & Sabatowski, R. (2017) · Pain · doi:10.1097/j.pain.0000000000000902 · Cited by 100 · see citing works
Garcia-Palacios, A., Herrero, R., Vizcaíno, Y., Belmonte, M. A., Castilla, D., Molinari, G., Baños, R. M., & Botella, C. (2015) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000000196 · Cited by 96 · see citing works
Don’t middle your MIDs: regression to the mean shrinks estimates of minimally important differences
Fayers, P. M., & Hays, R. D. (2014) · Quality of Life Research · doi:10.1007/s11136-013-0443-4 · Cited by 95 · see citing works
Miró, E., Lupiáñez, J., Martínez, M. P., Sánchez, A. I., Díaz-Piedra, C., Guzmán, M. A., & Buela-Casal, G. (2011) · Journal of Health Psychology · doi:10.1177/1359105310390544 · Cited by 87 · see citing works
Naeem, F., Phiri, P., Munshi, T., Rathod, S., Ayub, M., Gobbi, M., & Kingdon, D. (2015) · International Review of Psychiatry · doi:10.3109/09540261.2015.1067598 · Cited by 84 · cited 13× · see citing works
“…et al., 2007; Alda et al., 2011; Luciano et al., 2011, 2014; Wicksell et al., 2013), from medical/rheumatology departments (Vlaeyen et al., 1996; Nicassio et al., 1997; King et al., 2002; Williams et al., 2002; Thieme et al., 2003; Kashikar-Zuck et al., 2005; Falcao et al., 2008; Mir o et…”
BackgroundInfluential(2001) · PubMed · Cited by 79 · see citing works
Castel, A., Cascón, R., Padrol, A., Sala, J., & Rull, M. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2011.11.005 · Cited by 79 · cited 15× · see citing works
“Only one study had a total treatment time <5 h (Ang et al., 2010) and seven studies had a treatment time of >25 h (Wigers et al., 1996; Soares and Grossi, 2002; Thieme et al., 2003; Thieme et al., 2006; Falcao et al., 2008; Castel et al., 2012; Karlsson et al., 2015).”
BackgroundInfluentialAlda, M., Luciano, J. V., Andrés, E., Serrano-Blanco, A., Rodero, B., del Hoyo, Y. L., Roca, M., Moreno, S., Magallón, R., & García-Campayo, J. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3496 · Cited by 77 · cited 17× · see citing works
“…al., 2004; Edinger et al., 2005; Kashikar-Zuck et al., 2005; Thieme et al., 2006; Falcao et al., 2008; Castel et al., 2009, 2012; Ang et al., 2010; Alda et al., 2011; Luciano et al., 2011; Mir o et al., 2011; Kashikar-Zuck et al., 2012; Woolfolk et al., 2012; Mart ınez et al., 2014;…”
BackgroundResultInfluentialAre psychological treatments effective for fibromyalgia pain?
Thieme, K., & Gracely, R. H. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0065-6 · Cited by 75 · see citing works
CUSHING'S SYNDROME: CLINICAL DIFFERENTIAL DIAGNOSIS AND COMPLICATIONS
Hurxthal, L. M., & O'Sullivan, J. (1959) · Annals of Internal Medicine · doi:10.7326/0003-4819-51-1-1 · Cited by 67 · see citing works
Advancing psychological therapies for chronic pain
Eccleston, C., & Crombez, G. (2017) · F1000Research · doi:10.12688/f1000research.10612.1 · Cited by 67 · see citing works
Ang, D. C., Chakr, R., Mazzuca, S., France, C. R., Steiner, J., & Stump, T. (2010) · Arthritis Care & Research · doi:10.1002/acr.20119 · Cited by 66 · see citing works
Parra-Delgado, M., & Latorre-Postigo, J. M. (2013) · Cognitive Therapy and Research · doi:10.1007/s10608-013-9538-z · Cited by 65 · see citing works
Luciano, J. V., Martínez, N., Peñarrubia-María, M. T., Fernández-Vergel, R., García-Campayo, J., Verduras, C., Blanco, M. E., Jiménez, M., Ruiz, J. M., del Hoyo, Y. L., et al. (2011) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31820b131c · Cited by 65 · cited 1× · see citing works
“The follow-up data of Luciano et al., 2011 were reported in Luciano et al., 2013.”
MethodEULAR recommendations for management of fibromyalgia
Macfarlane, G. J., Kronisch, C., Atzeni, F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211587 · Cited by 62 · see citing works
Üçeyler, N., Burgmer, M., Friedel, E., Greiner, W., Petzke, F., Sarholz, M., Schiltenwolf, M., Winkelmann, A., Sommer, C., & Häuser, W. (2017) · Der Schmerz · doi:10.1007/s00482-017-0202-5 · Cited by 60 · see citing works
Self-citationCost-Utility of a Psychoeducational Intervention in Fibromyalgia Patients Compared With Usual Care
Luciano, J. V., Sabés-Figuera, R., Cardeñosa, E., Peñarrubia‐María, M. T., Fernández‐Vergel, R., García‐Campayo, J., Knapp, M. R. J., & Serrano‐Blanco, A. (2013) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318270f99a · Cited by 59 · see citing works
Soares, J. J. F., & Grossi, G. (2002) · Scandinavian Journal of Occupational Therapy · doi:10.1080/110381202753505845 · Cited by 50 · see citing works
Fibromyalgia: can online cognitive behavioral therapy help?
(2014) · PubMed Central · Cited by 35 · see citing works
Cognitive behaviour therapy in women with fibromyalgia: A randomized clinical trial
Karlsson, B., Burell, G. K., Anderberg, U. M., & Svärdsudd, K. (2015) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2015.04.027 · Cited by 33 · see citing works
Falcão, D. M., Sales, L., Leite, J. R., Feldman, D., Valim, V., & Natour, J. (2008) · Journal of Musculoskeletal Pain · doi:10.1080/10582450802161796 · Cited by 33 · see citing works
Cognitive‐behavioural group treatment with hypnosis: a randomized pilot trail in fibromyalgia
Castel, A., Salvat, M., Sala, J., & Rull, M. (2009) · Contemporary Hypnosis · doi:10.1002/ch.372 · Cited by 32 · see citing works
Cognitive behavioural therapies for fibromyalgia syndrome
Bernardy, K., Klose, P., Busch, A. J., Choy, E., & Häuser, W. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009796 · Cited by 26 · see citing works
Self-citationFibromyalgia: Can Online Cognitive Behavioral Therapy Help?
Menga, G., Dupre, B. J., Gauthier, C., Davis, W. E., Webb-Detiege, T., Scopelitis, E., Zakem, J., & Quinet, R. (2011) · Europe PMC (PubMed Central) · Cited by 22 · see citing works
Psychotherapie und psychologische Verfahren beim Fibromyalgiesyndrom
Köllner, V., Bernardy, K., Greiner, W., Krumbein, L., Lucius, H., Offenbächer, M., Sarholz, M., Settan, M., & Häuser, W. (2017) · Der Schmerz · doi:10.1007/s00482-017-0204-3 · Cited by 18 · see citing works
Self-citationAffective-cognitive behavioral therapy for fibromyalgia: A randomized controlled trial
Woolfolk, R. L., Allen, L. A., & Apter, J. T. (2012) · Pain Research and Treatment · doi:10.1155/2012/937873 · Cited by 17 · see citing works
Häuser, W., Klose, P., Welsch, P., Petzke, F. W., Nothacker, M., & Kopp, I. (2014) · Der Schmerz · doi:10.1007/s00482-014-1462-y · Cited by 16 · see citing works
Self-citationVerhaltenstherapeutische Konzepte in der Therapie chronischer Schmerzen
Kaiser, U., & Nilges, P. (2015) · Der Schmerz · doi:10.1007/s00482-014-1489-0 · Cited by 12 · see citing works
Psychological interventions for pediatric chronic pain – The good news and the challenges ahead
Kashikar‐Zuck, S. (2009) · Pain · doi:10.1016/j.pain.2009.11.001 · Cited by 8 · see citing works
Köllner, V., Bernardy, K., Greiner, W., Krumbein, L., Lucius, H., Offenbächer, M., Sarholz, M., Settan, M., & Häuser, W. (2017) · Der Schmerz · Cited by 6 · see citing works
Self-citationEfficacy of operant- and cognitive-behavioral pain treatment in fibromyalgia-syndrome
Thieme, K., Flor, H., & Turk, D. (2005) · Journal of Pain · doi:10.1016/j.jpain.2005.01.017 · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Moore R.A., 2008, Systematic Reviews in Pain Research: Methodology Refined
- Review Manager(RevMan) [Computer program]. (2014).The Nordic Center. Version Version 5.3.Copenhagen:The Nordic Cochrane Centre The Cochrane Collaboration.
Cited by
Sorted by citations
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24131 · Cited by 2,516 · see citing works
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C. A., Guyatt, G. H., Block, J. A., Callahan, L. F., Copenhaver, C., Dodge, C. V., Felson, D. T., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41142 · Cited by 2,088 · see citing works
“There is a wellestablished body of literature (19,20) supporting the use of CBT in chronic pain conditions, and CBT may have relevance for the management of OA.”
BackgroundFibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
Sarzi‐Puttini, P., Giorgi, V., Marotto, D., & Atzeni, F. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00506-w · Cited by 837 · see citing works
Management of functional neurological disorder
Gilmour, G. S., Nielsen, G., Teodoro, T., Yogarajah, M., Coebergh, J. A., Dilley, M. D., Martino, D., & Edwards, M. J. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09772-w · Cited by 169 · see citing works
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
Welsch, P., Üçeyler, N., Klose, P., Walitt, B. T., & Häuser, W. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010292.pub2 · Cited by 152 · see citing works
Self-citationHaugmark, T., Hagen, K. B., Smedslund, G., & Zangi, H. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221897 · Cited by 149 · see citing works
Fatigue in chronic liver disease: New insights and therapeutic approaches
Swain, M. G., & Jones, D. E. (2018) · Liver International · doi:10.1111/liv.13919 · Cited by 125 · see citing works
Moreno-Ligero, M., Moral-Muñoz, J. A., Salazar, A., & Failde, I. (2023) · JMIR mhealth and uhealth · doi:10.2196/40844 · Cited by 132 · see citing works
“Evidence showed that patients with FM who received CBT showed reduced pain and improved health-related QoL and functional disability more than patients receiving usual care, no treatment, or other nonpharmacological interventions [69].”
Current and Emerging Pharmacotherapy for Fibromyalgia
Tzadok, R., & Ablin, J. N. (2020) · Pain Research and Management · doi:10.1155/2020/6541798 · Cited by 122 · see citing works
“NYX-2925 ((2S,3R)-3-hydroxy-2-((R)-5-isobutyryl-1-oxo2,5-diazaspiro[3,4]octan-2-yl)butanamide) is a new NMDA receptor modulator which was shown by Khan et al.”
BackgroundSerrat, M., Sanabria‐Mazo, J. P., Almirall, M., Musté, M., Feliu‐Soler, A., Méndez-Ulrich, J. L., Sanz, A., & Luciano, J. V. (2021) · Physical Therapy · doi:10.1093/ptj/pzab200 · Cited by 114 · see citing works
Mascarenhas, R. O., de Souza, M. B., Oliveira, M. X., Lacerda, A. C. R., Mendonça, V. A., Henschke, N., & Oliveira, V. C. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.5651 · Cited by 108 · see citing works
Pérez-Aranda, A., Feliu-Soler, A., Montero-Marín, J., García-Campayo, J., Andrés-Rodríguez, L., Borràs, X., Rozadilla-Sacanell, A., Peñarrubia-Maria, M. T., Angarita-Osorio, N., McCracken, L. M., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001655 · Cited by 98 · see citing works
“In addition, aerobic exercise, multicomponent therapy, psychoeducation, and cognitive-behavior therapy (CBT) have proven their effectiveness in randomized controlled trials (RCTs), obtaining small to medium effect sizes.(6,7,37,43,51,52,61) At the same time, there are treatment developments that represent extensions o…”
BackgroundAnxiety disorders and medical comorbidity: Treatment implications
Meuret, A. E., Tunnell, N., & Roque, A. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9705-0_15 · Cited by 96 · see citing works
Serrat, M., Almirall, M., Musté, M., Sanabria‐Mazo, J. P., Feliu‐Soler, A., Méndez-Ulrich, J. L., Luciano, J. V., & Sanz, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103348 · Cited by 86 · see citing works
“Regarding pharmacological treatment, the European League against Rheumatism (EULAR) recommendation for FM patients is to only use medication to control pain and sleep disturbances [19].”
BackgroundMartinez-Calderon, J., García-Muñoz, C., Rufo-Barbero, C., Matias-Soto, J., & Cano-García, F. J. (2024) · The Journal of Pain · doi:10.1016/j.jpain.2023.09.013 · Cited by 79 · see citing works
Galvez-Sánchez, C. M., Montoro, C. I., Duschek, S., & del Paso, G. A. R. (2020) · Quality of Life Research · doi:10.1007/s11136-020-02457-x · Cited by 76 · see citing works
“In this sense, Cognitive Behavioral Therapy could be a relevant treatment given the central role of cognitive biases in catastrophizing [74, 75].”
BackgroundUnravelling Fibromyalgia—Steps toward Individualized Management
Häuser, W., Perrot, S., Clauw, D. J., & Fitzcharles, M.-A. (2018) · The Journal of Pain · doi:10.1016/j.jpain.2017.08.009 · Cited by 72 · see citing works
Self-citationFibromyalgia and Depression: A Literature Review of Their Shared Aspects
Yepez, D., Grandes, X. A., Manjunatha, R. T., Habib, S., & Sangaraju, S. L. (2022) · Cureus · doi:10.7759/cureus.24909 · Cited by 72 · see citing works
“Due to the impact that depressive symptoms have on the clinical and socio-economical aspects of patients with FM, another component of its management is psychological treatment: CBT as the treatment of choice, which has shown pain relief, improvement in quality of life, and depressive symptoms, among other effects [71…”
BackgroundBernardy, K., Klose, P., Welsch, P., & Häuser, W. (2019) · European Journal of Pain · doi:10.1002/ejp.1284 · Cited by 50 · see citing works
Fibromyalgia: A misconnection in a multiconnected world?
Perrot, S. (2019) · European Journal of Pain · doi:10.1002/ejp.1367 · Cited by 51 · see citing works
Barrenengoa‐Cuadra, M. J., Muñoa‐Capron‐Manieux, M., Fernández‐Luco, M., Angón‐Puras, L. Á., Romón‐Gómez, A. J., Azkuenaga, M., Etxebarria, A., Orrantia, G., Pikaza, A., Uribe‐Etxebarria, L., et al. (2021) · European Journal of Pain · doi:10.1002/ejp.1738 · Cited by 45 · see citing works
“Nonpharmacological interventions, such as physical exercise (Bidonde et al., 2017) and cognitive behavioural therapy (Bernardy et al., 2018), have provided evidence- based benefits (García et al., 2018) and are recommended by guidelines (Macfarlane et al., 2017).”
BackgroundBasic Body Awareness Therapy in patients suffering from fibromyalgia: A randomized clinical trial
Bravo, C., Skjærven, L. H., Espart, A., Sein-Echaluce, L. G., & Catalán-Matamoros, D. (2018) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2018.1467520 · Cited by 45 · see citing works
Pain without inflammation in rheumatic diseases
Lampa, J. (2019) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.101439 · Cited by 47 · see citing works
Disentangling Diagnosis and Management of Fibromyalgia
Kang, J., Choi, S.-E., Park, D.-J., & Lee, S. (2021) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2022.29.1.4 · Cited by 48 · see citing works
“FM and its comorbidities negatively impact daily activities and healthrelated quality of life (HRQoL); they impose a major socioeconomic burden on healthcare systems and patients [4].”
BackgroundInfluentialMaroti, D., Lumley, M. A., Schubiner, H., Lilliengren, P., Bileviciute-Ljungar, I., Ljótsson, B., & Johansson, R. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.111068 · Cited by 40 · see citing works
Serrat, M., Omana, M. C. I., Albajes, K., Solé, S., Almirall, M., Luciano, J. V., & Feliu‐Soler, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph181910300 · Cited by 43 · see citing works
“On the other hand, CBT has been proven to be also efficacious (with small-to-medium effect sizes) for improving pain, health-related quality of life, negative mood, disability and fatigue in patients with FM [34,35].”
BackgroundFibromyalgia: Understanding, Diagnosis and Modern Approaches to Treatment
Filipović, T., Filipović, A., Nikolić, D., Gimigliano, F., Stevanov, J., Hrković, M., & Bosanac, I. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030955 · Cited by 46 · see citing works
Serrat, M., Albajes, K., Navarrete, J., Almirall, M., Girbés, E. L., Neblett, R., Luciano, J. V., Queraltó, J. M., & Feliu‐Soler, A. (2022) · Behaviour Research and Therapy · doi:10.1016/j.brat.2022.104188 · Cited by 39 · see citing works
Outpatient Engagement and Predicted Risk of Suicide Attempts in Fibromyalgia
McKernan, L. C., Lenert, M. C., Crofford, L. J., & Walsh, C. G. (2018) · Arthritis Care & Research · doi:10.1002/acr.23748 · Cited by 37 · see citing works
“Cognitive behavioral therapy in particular has been shown to improve outcomes in FM by improving mood, pain- related disability, and pain severity at follow- up (32).”
BackgroundMirtazapine for fibromyalgia in adults
Welsch, P., Bernardy, K., Derry, S., Moore, A., & Häuser, W. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012708.pub2 · Cited by 38 · see citing works
Self-citationSerrat, M., Sanabria‐Mazo, J. P., Almirall, M., Musté, M., Feliu‐Soler, A., Méndez-Ulrich, J. L., Sanz, A., & Luciano, J. V. (2020) · doi:10.31234/osf.io/kj8sp · Cited by 35 · see citing works
“38 Mindfulness-based interventions are a form of structured training aimed at helping people to relate to their physical and psychological conditions in more accepting and non-judgmental ways.”
BackgroundMethodMaroti, D., Ek, J., Widlund, R.-M., Schubiner, H. H., Lumley, M. A., Lilliengren, P., Bilevičiūtė-Ljungar, I., Ljótsson, B., & Johansson, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.620359 · Cited by 32 · see citing works
“In addition, in a meta-analysis of CBT for fibromyalgia (which was the most prevalent condition in our sample), Bernardy et al. (22) found that only 13.3% of patients received a 50% symptom reduction at the end of treatment, whereas it was observed for 23.1% of the patients in this study and slightly more at follow-up.”
BackgroundInfluentialSamami, E., Shahhosseini, Z., & Elyasi, F. (2021) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-021-09794-0 · Cited by 34 · see citing works
Wu, Y.-Q., Long, Y., Peng, W., Gong, C., Liu, Y.-Q., Peng, X.-M., Zhong, Y.-B., Luo, Y., & Wang, M. (2023) · Journal of Medical Internet Research · doi:10.2196/42090 · Cited by 34 · see citing works
Prados, G., Miró, E., Martínez, M. P., Sánchez, A. I., Lami, M. J., & Cáliz, R. (2020) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2020.04.002 · Cited by 29 · see citing works
Sanabria‐Mazo, J. P., Montero‐Marín, J., Feliu‐Soler, A., Gasión, V., Navarro‐Gil, M., Morillo‐Sarto, H., Colomer‐Carbonell, A., Borràs, X., Tops, M., Luciano, J. V., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103246 · Cited by 27 · see citing works
Galvão-Moreira, L. V., de Castro, L. O., Moura, E. C. R., de Oliveira, C. M. B., Neto, J. N., Gomes, L. M. R. D. S., & Leal, P. D. C. (2020) · Modern Rheumatology · doi:10.1080/14397595.2020.1829339 · Cited by 30 · see citing works
Haugmark, T., Hagen, K. B., Provan, S. A., Smedslund, G., & Zangi, H. A. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046943 · Cited by 28 · see citing works
Bidonde, J., Fisher, E., Perrot, S., Moore, R. A., Bell, R. F., Makri, S., & Häuser, W. (2023) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2023.152248 · Cited by 27 · see citing works
Self-citationHsiao, I.-H., & Lin, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2242074 · Cited by 27 · see citing works
Pers, Y., Nguyen, C., Borie, C., Daste, C., Kirren, Q., Lopez, C., Ouvrard, G., Ruscher, R., Argenson, J., Bardoux, S., et al. (2024) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2024.101883 · Cited by 25 · see citing works
Zabihiyeganeh, M., Afshar, S. V., Kadijani, A. A., Jafari, D., Bagherifard, A., Janbozorgi, M., Akbari, A., & Mirzaei, A. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.01.003 · Cited by 24 · see citing works
Areso-Bóveda, P. B., Mambrillas-Varela, J., García-Gómez, B., Moscosio-Cuevas, J. I., González-Lama, J., Arnaiz-Rodríguez, E., del Barco, M. B. A., & Teodoro-Blanco, P. S. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-022-05284-y · Cited by 25 · see citing works
Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery?
Varrassi, G., Rekatsina, M., Perrot, S., Bouajina, E., Paladini, A., Coaccioli, S., Tamayo, M. A. N., & Sarzi‐Puttini, P. (2023) · Cureus · doi:10.7759/cureus.44852 · Cited by 24 · see citing works
“CBT can intervene to restore a more holistic balance, and has been found in a meta-analysis to offer ≥50% pain relief and significantly improve negative moods, functional deficits, insomnia, and fatigue [72].”
BackgroundCliment‐Sanz, C., Hamilton, K. R., Martínez-Navarro, O., Briones‐Vozmediano, E., Gracia-Lasheras, M., Fernández‐Lago, H., Valenzuela‐Pascual, F., & Finan, P. H. (2023) · Disability and Rehabilitation · doi:10.1080/09638288.2023.2280057 · Cited by 25 · see citing works
“Prior systematic and meta-analytic work supports in person CBT for fibromyalgia pain reduction in the short term (i.e., ≤3 months); however, there was no strong support for long-term (i.e., ≤1 year) pain relief, and mixed reports on the clinical relevance of these reductions [77,78].”
Martínez, M. P., Sánchez, A. I., Prados, G., Lami, M. J., Villar, B., & Miró, E. (2021) · The Spanish Journal of Psychology · doi:10.1017/sjp.2021.30 · Cited by 24 · see citing works
Eastwood, F., & Godfrey, E. (2024) · British Journal of Pain · doi:10.1177/20494637231221451 · Cited by 22 · see citing works
Britto, A., Rodrigues, V. P., dos Santos, A. M., Rizzini, M., Britto, P., Britto, L., & Garcia, J. B. S. (2020) · Musculoskeletal Care · doi:10.1002/msc.1481 · Cited by 25 · see citing works
Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management
Kośnik, A., & Wójcicki, M. (2022) · Gastroenterology Review · doi:10.5114/pg.2022.114594 · Cited by 22 · see citing works
“Cognitive behavioural therapy may play a beneficial role in managing fatigue for some patients [54].”
BackgroundMontero-Marin, J., Van Gordon, W., Shonin, E., Navarro-Gil, M., Gasión, V., López-del-Hoyo, Y., Luciano, J. V., & Garcia-Campayo, J. (2020) · Mindfulness · doi:10.1007/s12671-019-01302-8 · Cited by 22 · see citing works
Psychoeducation for Patients with Fibromyalgia: A Systematic Review
Gómez-de-Regil, L. (2021) · Healthcare · doi:10.3390/healthcare9060737 · Cited by 24 · see citing works
“Systematic reviews have synthesized the results from psychotherapeutic interventions implemented in patients with FM [26], for instance, for the management of physical pain [19], the use of CBT [27], mindfulness [28], or guided imagery and hypnosis [29], and the group [20] or Internet [30] modalities.”
BackgroundCojocaru, C. M., Popa, C. O., Schenk, A., Suciu, B. A., & Szasz, S. (2023) · Medicine and Pharmacy Reports · doi:10.15386/mpr-2661 · Cited by 21 · see citing works
“According to existing recommendations concerning the specificity of the psychotherapeutic treatment, we did not assess the risk of bias related to “blinding participants and personnel” [27,28].”
MethodResultPsychological therapies for chronic widespread pain and fibromyalgia syndrome
Häuser, W., & Jones, G. T. (2019) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.05.001 · Cited by 23 · see citing works
Self-citationRobbins, R. C., Helmer, D. A., Monahan, P., Hunt, S. C., McAndrew, L. M., Nazario, M., Brown, W. J., Chao, W., Navarro, A., & Sall, J. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.01.031 · Cited by 20 · see citing works
“5% of participants in the control arms.(13) A meta-analysis of 9 clinical trials for patients”
BackgroundMirtazapine for fibromyalgia in adults
Welsch, P., Bernardy, K., Derry, S., Moore, R. A., & Häuser, W. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012708 · Cited by 20 · see citing works
Self-citationCheng, D. K., Lai, K. S. P., Pico-Espinosa, O. J., Rice, D., Chung, C. L. R., Modarresi, G., & Sud, A. (2021) · Pain medicine (Malden, Mass.) · doi:10.1093/pm/pnab248 · Cited by 15 · see citing works
“This was larger than for in-person CBT where the only meta-analysis from a high-quality review [50] Figure 1.”
Terpstra, J. A., van der Vaart, R., Ding, H. J., Kloppenburg, M., & Evers, A. W. M. (2021) · Internet Interventions · doi:10.1016/j.invent.2021.100444 · Cited by 19 · see citing works
“…to be an effective selfmanagement intervention for various somatic conditions and symptoms (e.g., fibromyalgia, rheumatoid arthritis, and chronic pain [Bernardy et al., 2018; Butler et al., 2006; Cunningham and Kashikar-Zuck, 2013; Dures and Hewlett, 2012; Evers et al., 2002; Lami et al., 2013]).”
BackgroundCuenca‐Martínez, F., Suso‐Martí, L., Fernández‐Carnero, J., Muñoz-Alarcos, V., & Sempere‐Rubio, N. (2023) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2023.152216 · Cited by 22 · see citing works
Gómez-Pérez, M. C., García-Palacios, A., Castilla, D., Zaragozá, I., & Suso-Ribera, C. (2020) · Pain Research and Management · doi:10.1155/2020/7897268 · Cited by 18 · see citing works
“mental distress are obtained with CBT, while pain intensity changes tend to be smaller [8, 9].”
BackgroundLappalainen, P., Keinonen, K., Lappalainen, R., Selinheimo, S., Vuokko, A., Sainio, M., Liesto, S., Tolvanen, A., & Paunio, T. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111830 · Cited by 17 · see citing works
Pérez-Aranda, A., Barceló-Soler, A., Andrés-Rodríguez, L., Peñarrubia-María, M. T., Tuccillo, R., Borraz-Estruch, G., García-Campayo, J., Feliu-Soler, A., & Luciano, J. V. (2017) · Mindfulness & Compassion · doi:10.1016/j.mincom.2017.10.002 · Cited by 17 · see citing works
Lin, H.-M., Hsieh, P.-S., Chen, N.-C., Tsai, C.-H., Kuo, W.-F., Lee, Y., & Hung, K.-C. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1083095 · Cited by 17 · see citing works
“(43) 60% 61 30 100%/0/0 CBT-I (16) No treatment (14) Post treatment a, c USA”
ResultInfluentialBurgess, H. J., Bahl, S., Wilensky, K., Spence, E., Jouppi, R. J., Rizvydeen, M., Goldstein, C. A., Kim, H. M., Williams, D. A., & Burns, J. W. (2023) · Pain Medicine · doi:10.1093/pm/pnad007 · Cited by 17 · see citing works
Rubio-Zarapuz, A., Apolo-Arenas, M. D., Tomás-Carús, P., Tornero-Aguilera, J. F., Clemente‐Suárez, V. J., & Parraça, J. A. (2024) · Medicina · doi:10.3390/medicina60030404 · Cited by 17 · see citing works
Serrat, M., Sanabria‐Mazo, J. P., García-Troiteiro, E., Fontcuberta, A., Canedo, C. M., Almirall, M., Feliu‐Soler, A., Méndez-Ulrich, J. L., Sanz, A., & Luciano, J. V. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17020634 · Cited by 16 · see citing works
“CBT-based treatments have favoured the acceptance of FM, strengthening of self-efficacy, development of coping strategies, and the reduction in depressive moods [16].”
Demori, I., Molinari, E., Rapallo, F., Mucci, V., Marinelli, L., Losacco, S., & Burlando, B. (2022) · Healthcare · doi:10.3390/healthcare10101975 · Cited by 16 · see citing works
“Accordingly, cognitive-behavioral therapy is the most widely studied and practiced psychotherapy for FM, showing improvements in pain, physical functioning, and mood [68].”
BackgroundDonisi, V., Lucia, A. D., Pasini, I., Gandolfi, M., Schweiger, V., Piccolo, L. D., & Perlini, C. (2023) · Healthcare · doi:10.3390/healthcare11131845 · Cited by 17 · see citing works
“Among the psychological interventions for FMS, face-toface cognitive behavioral therapies (CBT) stand out as the most effective treatment [6].”
BackgroundMethodBarrenengoa‐Cuadra, M. J., Angón‐Puras, L. Á., Moscosio-Cuevas, J. I., González-Lama, J., Fernández‐Luco, M., & Ballarín, R. G. (2020) · Atención Primaria · doi:10.1016/j.aprim.2019.10.007 · Cited by 16 · see citing works
Bellomo, T. R., Schrepf, A., Kruger, G. H., Lumley, M. A., Schubiner, H. H., Clauw, D. J., Williams, D. A., & Harte, S. E. (2020) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000829 · Cited by 15 · see citing works
Diagnostic and therapeutic care pathway for fibromyalgia
Sarzi‐Puttini, P., Giorgi, V., Atzeni, F., Gorla, R., Kosek, E., Choy, E., Bazzichi, L. M., Häuser, W., Ablin, J. N., Aloush, V., et al. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/zcp5hz · Cited by 18 · see citing works
“In support of this, many studies demonstrated that cognitive-behavioural therapy is very effective in FM (46).”
Self-citationFibromyalgia in Older Individuals
Minerbi, A., & Fitzcharles, M. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00879-x · Cited by 16 · see citing works
Coping with fibromyalgia - a focus group study
Hamama, L., & Itzhaki, M. (2023) · International Journal of Qualitative Studies on Health and Well-Being · doi:10.1080/17482631.2023.2204622 · Cited by 20 · see citing works
Macfarlane, G. J., Beasley, M., SCOTT, N. W., Chong, H. Y., McNamee, P., McBeth, J., Basu, N., Hannaford, P. C., Jones, G. T., Keeley, P., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219091 · Cited by 15 · see citing works
“31 It is already known that CBT is effective in the management of fibromyalgia 11 and this study provides evidence that a wider range of patients may benefit in terms of quality of life.”
Serrat, M., Ferrés, S., Auer, W., Almirall, M., Lluch, E., D’Amico, F., Maes, M. H. J., Lorente, S., Navarrete, J., Montero‐Marín, J., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1046613 · Cited by 14 · see citing works
“Concurrently, there is high agreement among clinical guidelines that CBT and therapeutic physical exercise should constitute the main therapeutic elements when treating FM (Jones et al., 2006; Bernardy et al., 2010; Sosa-Reina et al., 2017; Bernardy et al., 2018); furthermore, combining both interventions has been sho…”
BackgroundHedman‐Lagerlöf, M., Gasslander, N., Hoffmann, A. A., Bragesjö, M., Etzell, A., Ezra, S., Frostell, E., Hedman‐Lagerlöf, E., Ivert, C., Liliequist, B. E., et al. (2023) · Pain · doi:10.1097/j.pain.0000000000003128 · Cited by 15 · see citing works
“7 We used a rigorous control condition considering that the T-CBT protocol 10 has been in use at a tertiary pain clinic for approximately 10 years.”
InfluentialProblem gambling during Covid-19
Frisone, F., Alibrandi, A., & Settineri, S. (2020) · Mediterranean Journal of Clinical Psychology · doi:10.6092/2282-1619/mjcp-2457 · Cited by 15 · see citing works
Jacobs, H., Bockaert, M., Bonte, J., D'Haese, M., Degrande, J., Descamps, L., Detaeye, U., Goethals, W., Janssens, J., Matthys, K., et al. (2019) · Journal of clinical rheumatology · doi:10.1097/rhu.0000000000001120 · Cited by 13 · see citing works
Belanger, H. G., Wortzel, H. S., Vanderploeg, R. D., & Cooper, D. B. (2019) · The Clinical Neuropsychologist · doi:10.1080/13854046.2019.1699166 · Cited by 15 · see citing works
A capital role for the brain’s insula in the diverse fibromyalgia-associated symptoms
Paepe, B. D., Smet, J., Baeken, C., Oosterwijck, J. V., & Meeus, M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110077 · Cited by 15 · see citing works
Progress towards improved non-pharmacological management of fibromyalgia
Pinto, A. M., Geenen, R., Castilho, P., & da Silva, J. A. P. (2020) · Joint Bone Spine · doi:10.1016/j.jbspin.2020.02.005 · Cited by 13 · see citing works
Hennemann, S., Böhme, K., Kleinstäuber, M., Ruckes, C., Baumeister, H., Daniel Ebert, D., Küchler, A.-M., & Witthöft, M. (2022) · Behavior Therapy · doi:10.1016/j.beth.2022.06.006 · Cited by 11 · see citing works
Borst, M., Moeyaert, M., & van Rood, Y. (2024) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2024.2314883 · Cited by 12 · see citing works
Pain Management: Assembling a Tool Kit, Building a Life
Boehnke, K. F. (2018) · JAMA · doi:10.1001/jama.2018.17722 · Cited by 12 · see citing works
Treatment preferences in fibromyalgia patients: A cross‐sectional web‐based survey
Valentini, E., Fetter, E., & Orbell, S. (2020) · European Journal of Pain · doi:10.1002/ejp.1570 · Cited by 14 · see citing works
Efeito de dois tratamentos de fisioterapia na fibromialgia: ensaio paralelo randomizado
Matsutani, L. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-02072018-153750 · Cited by 12 · see citing works
McIlroy, S., Vaughan, B., Crowe, H., & Bearne, L. (2022) · Musculoskeletal Care · doi:10.1002/msc.1672 · Cited by 11 · see citing works
Pasini, I., Perlini, C., Donisi, V., Mason, A., Schweiger, V., Secchettin, E., Lugoboni, F., Valenza, G., & Piccolo, L. D. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20053973 · Cited by 12 · see citing works
“Moreover, the literature tends to report mainly the results of group-specific therapies [21,22,28,32], compared to individual ones, which are more variable in relation to patient characteristics, require greater economic resources, time and staff availability.”
BackgroundResultGungormus, D. B., Fernández-Martín, M., Ortigosa-Luque, M. E., & Pérez‐Mármol, J. M. (2023) · Pain Management Nursing · doi:10.1016/j.pmn.2023.06.014 · Cited by 12 · see citing works
Fibromyalgia syndrome—a bodily distress disorder/somatic symptom disorder?
Häuser, W., Fitzcharles, M., & Henningsen, P. (2025) · PAIN Reports · doi:10.1097/pr9.0000000000001223 · Cited by 14 · see citing works
“15,33,34 With this background, we will now discuss problems when applying SSD B1 to B3 criteria for people with FMS.”
InfluentialSelf-citationMoore, A., Fisher, E., Häuser, W., Bell, R. F., Perrot, S., Bidonde, J., Makri, S., & Straube, S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013151.pub2 · Cited by 11 · see citing works
Self-citationAguilera, M., Paz, C., Salla, M., Compañ, V., Medina, J. C., Medeiros-Ferreira, L., & Feixas, G. (2022) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2022.100296 · Cited by 11 · see citing works
Crump, L., & LaChapelle, D. L. (2022) · Canadian Journal of Pain · doi:10.1080/24740527.2022.2078183 · Cited by 10 · see citing works
Seaton, N., Moss-Morris, R. E., Hulme, K., Macaulay, H., & Hudson, J. L. (2023) · BJPsych Open · doi:10.1192/bjo.2023.519 · Cited by 10 · see citing works
Guidelines on Treating Fibromyalgia With Nonpharmacological Therapies in China
Li, X., Pan, H., Wang, L., Zhou, Q. X., Ma, Y., Wang, Q., Wang, M., Xie, Z., Li, H., Chen, Z., et al. (2025) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.70044 · Cited by 11 · see citing works
Hennemann, S., Witthöft, M., Kleinstäuber, M., Böhme, K., Baumeister, H., Ebert, D. D., & Probst, T. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.110761 · Cited by 10 · see citing works
Prados, G., Miró, E., Martínez, M. P., Sánchez, A. I., Pichot, V., Medina-Casado, M., & Chouchou, F. (2022) · Brain Sciences · doi:10.3390/brainsci12070947 · Cited by 11 · see citing works
“Thus, they may enhance the efficiency of this type of psychological treatment, which has traditionally been applied focusing exclusively on pain or insomnia among FM patients [38,44].”
BackgroundTurcotte, K., Oelke, N. D., Whitaker, G. M., Holtzman, S., O’Connor, B. P., Pearson, N., & Teo, M. (2023) · Rheumatology International · doi:10.1007/s00296-023-05403-5 · Cited by 13 · see citing works
van Westrienen, P. E., Pisters, M. F., Gerrits, M. M. J. G., Veenhof, C., & de Wit, N. J. (2019) · JMIR Mental Health · doi:10.2196/12203 · Cited by 10 · see citing works
“Many studies have already been conducted in patients with chronic MUPS to assess the efficacy of psychological, pharmacological, exercise therapy, or combined treatment approaches [13-18].”
BackgroundInfluentialBaronian, R., & Leggett, S. J. (2019) · British Journal of Pain · doi:10.1177/2049463719858119 · Cited by 10 · see citing works
Jandaghi, G., Firoozi, M., & Zia-Tohidi, A. (2020) · Health Promotion Perspectives · doi:10.34172/hpp.2020.31 · Cited by 9 · see citing works
- Authors
- Bernardy, K., Klose, P., Welsch, P., & Häuser, W.
- Affiliations
- BG University Hospital Bergmannsheil Bochum (DE)
- Kliniken Essen-Mitte (DE)
- Klinikum Saarbrücken (DE)
- Corresponding author
- Häuser, W.
- ORCID
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2017-10-06
- Volume
- 22
- Issue
- 2
- Pages
- 242-260
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W2761624529
- Cited by
- 217
- References
- 70
- Citations by year
- 2026: 17 · 2025: 24 · 2024: 19 · 2023: 33 · 2022: 33 · 2021: 27 · 2020: 30 · 2019: 17 · 2018: 14 · 2017: 3
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Pain (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Medicine › Pharmacology › Musculoskeletal pain and rehabilitation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Myofascial pain diagnosis and treatment
- Keywords
- fibromyalgia, cognitive behavioral therapy, analgesia, health-related quality of life, negative mood, fatigue, disability, treatment acceptability, treatment safety, non-pharmacological treatment, waitlist control, attentional control, usual care, long-term follow-up, tolerability, chronic pain management
- MeSH terms
- Duloxetine Hydrochloride, Pregabalin, Adaptation, Psychological, Fibromyalgia, Humans, Quality of Life, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review